Blood Screening Market Size, Share & Growth Analysis Report

Market Segmentation

Blood Screening Market, By Technology (2021-2033)

Nucleic Acid Amplification Test (NAT)
ELISA
Chemiluminescence Immunoassay (CLIA & EIA )
Next Generation Sequencing (NGS)
Western Blotting (WB)

Blood Screening Market, By Product (2021-2033)

Reagent
Instrument

Regional Blood Screening Market

North America
1. North America Blood Screening Market, By Technology
  1. Nucleic Acid Amplification Test (NAT)
  2. ELISA
  3. Chemiluminescence Immunoassay (CLIA & EIA )
  4. Next Generation Sequencing (NGS)
  5. Western Blotting (WB)
2. North America Blood Screening Market, By Product
  1. Reagent
  2. Instrument
3. U.S.
  1. U.S. Blood Screening Market, By Technology
    1. Nucleic Acid Amplification Test (NAT)
    2. ELISA
    3. Chemiluminescence Immunoassay (CLIA & EIA )
    4. Next Generation Sequencing (NGS)
    5. Western Blotting (WB)
  2. U.S. Blood Screening Market, By Product
    1. Reagent
    2. Instrument
4. Canada
Europe
1. Europe Blood Screening Market, By Technology
  1. Nucleic Acid Amplification Test (NAT)
  2. ELISA
  3. Chemiluminescence Immunoassay (CLIA & EIA )
  4. Next Generation Sequencing (NGS)
  5. Western Blotting (WB)
2. Europe Blood Screening Market, By Product
  1. Reagent
  2. Instrument
3. U.K.
  1. U.K. Blood Screening Market, By Technology
    1. Nucleic Acid Amplification Test (NAT)
    2. ELISA
    3. Chemiluminescence Immunoassay (CLIA & EIA )
    4. Next Generation Sequencing (NGS)
    5. Western Blotting (WB)
  2. U.K. Blood Screening Market, By Product
    1. Reagent
    2. Instrument
4. Germany
5. France
6. Spain
7. Italy
8. Russia
9. Nordic
10. Benelux
11. Rest of Europe
APAC
1. APAC Blood Screening Market, By Technology
  1. Nucleic Acid Amplification Test (NAT)
  2. ELISA
  3. Chemiluminescence Immunoassay (CLIA & EIA )
  4. Next Generation Sequencing (NGS)
  5. Western Blotting (WB)
2. APAC Blood Screening Market, By Product
  1. Reagent
  2. Instrument
3. China
  1. China Blood Screening Market, By Technology
    1. Nucleic Acid Amplification Test (NAT)
    2. ELISA
    3. Chemiluminescence Immunoassay (CLIA & EIA )
    4. Next Generation Sequencing (NGS)
    5. Western Blotting (WB)
  2. China Blood Screening Market, By Product
    1. Reagent
    2. Instrument
4. Korea
5. Japan
6. India
7. Australia
8. Singapore
9. Taiwan
10. South East Asia
11. Rest of Asia-Pacific
Middle East and Africa
1. Middle East and Africa Blood Screening Market, By Technology
  1. Nucleic Acid Amplification Test (NAT)
  2. ELISA
  3. Chemiluminescence Immunoassay (CLIA & EIA )
  4. Next Generation Sequencing (NGS)
  5. Western Blotting (WB)
2. Middle East and Africa Blood Screening Market, By Product
  1. Reagent
  2. Instrument
3. UAE
  1. UAE Blood Screening Market, By Technology
    1. Nucleic Acid Amplification Test (NAT)
    2. ELISA
    3. Chemiluminescence Immunoassay (CLIA & EIA )
    4. Next Generation Sequencing (NGS)
    5. Western Blotting (WB)
  2. UAE Blood Screening Market, By Product
    1. Reagent
    2. Instrument
4. Turkey
5. Saudi Arabia
6. South Africa
7. Egypt
8. Nigeria
9. Rest of MEA
LATAM
1. LATAM Blood Screening Market, By Technology
  1. Nucleic Acid Amplification Test (NAT)
  2. ELISA
  3. Chemiluminescence Immunoassay (CLIA & EIA )
  4. Next Generation Sequencing (NGS)
  5. Western Blotting (WB)
2. LATAM Blood Screening Market, By Product
  1. Reagent
  2. Instrument
3. Brazil
  1. Brazil Blood Screening Market, By Technology
    1. Nucleic Acid Amplification Test (NAT)
    2. ELISA
    3. Chemiluminescence Immunoassay (CLIA & EIA )
    4. Next Generation Sequencing (NGS)
    5. Western Blotting (WB)
  2. Brazil Blood Screening Market, By Product
    1. Reagent
    2. Instrument
4. Mexico
5. Argentina
6. Chile
7. Colombia
8. Rest of LATAM